These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 10498626

  • 21. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
    Woodward JE, Salam A, Logar AJ, Schaefer AT, Rao AS.
    Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
    [Abstract] [Full Text] [Related]

  • 22. Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts.
    Graves SS, Storer BE, Butts TM, Storb R.
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1650-4. PubMed ID: 23994246
    [Abstract] [Full Text] [Related]

  • 23. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
    Wekerle T, Sayegh MH, Ito H, Hill J, Chandraker A, Pearson DA, Swenson KG, Zhao G, Sykes M.
    Transplantation; 1999 Nov 15; 68(9):1348-55. PubMed ID: 10573075
    [Abstract] [Full Text] [Related]

  • 24. Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.
    Sandmaier BM, Bethge WA, Wilbur DS, Hamlin DK, Santos EB, Brechbiel MW, Fisher DR, Storb R.
    Blood; 2002 Jul 01; 100(1):318-26. PubMed ID: 12070043
    [Abstract] [Full Text] [Related]

  • 25. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD, Pham S, Li S, Aitouche A.
    Transplantation; 2003 Sep 27; 76(6):988-94. PubMed ID: 14508367
    [Abstract] [Full Text] [Related]

  • 26. Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.
    Chen Y, Fukuda T, Thakar MS, Kornblit BT, Storer BE, Santos EB, Storb R, Sandmaier BM.
    Cytotherapy; 2011 Nov 27; 13(10):1269-80. PubMed ID: 21846291
    [Abstract] [Full Text] [Related]

  • 27. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS, Mathes DW, Georges GE, Kuhr CS, Chang J, Butts TM, Storb R.
    Transplantation; 2012 Sep 27; 94(6):562-8. PubMed ID: 22929594
    [Abstract] [Full Text] [Related]

  • 28. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
    Baron F, Sandmaier BM, Zellmer E, Sorror M, Storer B, Storb R.
    Biol Blood Marrow Transplant; 2006 Aug 27; 12(8):813-7. PubMed ID: 16864051
    [Abstract] [Full Text] [Related]

  • 29. Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts.
    Yu C, Seidel K, Nash RA, Deeg HJ, Sandmaier BM, Barsoukov A, Santos E, Storb R.
    Blood; 1998 Apr 01; 91(7):2581-7. PubMed ID: 9516160
    [Abstract] [Full Text] [Related]

  • 30. Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation.
    Zaucha JA, Yu C, Lothrop CD, Nash RA, Sale G, Georges G, Kiem HP, Niemeyer GP, Dufresne M, Cao Q, Storb R.
    Biol Blood Marrow Transplant; 2001 Apr 01; 7(1):14-24. PubMed ID: 11215693
    [Abstract] [Full Text] [Related]

  • 31. What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?
    Xun CQ, Little MT, Zellmer E, Yu C, Zaucha JM, Sale GE, Storer B, Storb R.
    Transplantation; 2002 Jan 27; 73(2):310-3. PubMed ID: 11821753
    [Abstract] [Full Text] [Related]

  • 32. CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation.
    Bruno B, Nash RA, Wallace PM, Gass MJ, Thompson J, Storb R, McSweeney PA.
    Transplantation; 1999 Aug 15; 68(3):338-44. PubMed ID: 10459536
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease.
    Lee YH, Miki T, Kuddus R, Tandin A, Goller AL, Subbotin V, Fung JJ, Peach R, Valdivia LA, Rao AS.
    Transplant Proc; 2000 Aug 15; 32(5):1032-3. PubMed ID: 10936336
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.
    Georges GE, Storb R, Thompson JD, Yu C, Gooley T, Bruno B, Nash RA.
    Blood; 2000 May 15; 95(10):3262-9. PubMed ID: 10807798
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.